Twist Bioscience to Report Fiscal 2025 First Quarter Financial Results on Monday, February 3, 2025
Twist Bioscience (NASDAQ: TWST) has announced it will release its fiscal 2025 first quarter financial results for the period ended December 31, 2024, before market opening on February 3, 2025. The company will host a conference call and live audio webcast for analysts and investors at 8:00 AM Eastern Time on the same day.
Participants interested in joining via telephone must pre-register through the company's Investor Relations website. The financial results press release will be available on the company's website in the Investor Relations section. A webcast replay will be accessible for two weeks following the call.
Twist Bioscience (NASDAQ: TWST) ha annunciato che pubblicherà i suoi risultati finanziari del primo trimestre dell'anno fiscale 2025 per il periodo conclusosi il 31 dicembre 2024, prima dell'apertura del mercato il 3 febbraio 2025. L'azienda ospiterà una conference call e un webcast audio dal vivo per analisti e investitori alle 8:00 ora orientale dello stesso giorno.
I partecipanti interessati a unirsi tramite telefono devono registrarsi in anticipo sul sito web delle Relazioni con gli Investitori dell'azienda. Il comunicato stampa dei risultati finanziari sarà disponibile sul sito web dell'azienda nella sezione Relazioni con gli Investitori. Una registrazione del webcast sarà accessibile per due settimane dopo la chiamata.
Twist Bioscience (NASDAQ: TWST) ha anunciado que publicará sus resultados financieros del primer trimestre del año fiscal 2025 para el período que finalizó el 31 de diciembre de 2024, antes de la apertura del mercado el 3 de febrero de 2025. La compañía llevará a cabo una conferencia telefónica y un webcast de audio en vivo para analistas e inversores a las 8:00 AM Hora del Este el mismo día.
Los participantes interesados en unirse por teléfono deben preinscribirse a través del sitio web de Relaciones con Inversores de la compañía. El comunicado de prensa de los resultados financieros estará disponible en el sitio web de la compañía en la sección de Relaciones con Inversores. Una repetición del webcast estará accesible durante dos semanas después de la llamada.
트위스트 바이오사이언스 (NASDAQ: TWST)는 2025 회계연도 1분기 재무 결과를 2024년 12월 31일로 마감된 기간에 대해 2025년 2월 3일 시장 개장 전에 발표할 것이라고 발표했습니다. 회사는 같은 날 동부 표준시 오전 8시에 분석가 및 투자자를 위한 전화 회의와 라이브 오디오 웹캐스트를 개최할 예정입니다.
전화로 참여하고자 하는 참가자는 회사의 투자자 관계 웹사이트를 통해 사전 등록해야 합니다. 재무 결과에 대한 보도 자료는 회사 웹사이트의 투자자 관계 섹션에서 확인할 수 있습니다. 웨브캐스트 재생은 통화 후 2주 동안 접근할 수 있습니다.
Twist Bioscience (NASDAQ: TWST) a annoncé qu'il publiera ses résultats financiers du premier trimestre de l'exercice 2025 pour la période se terminant le 31 décembre 2024, avant l'ouverture des marchés le 3 février 2025. L'entreprise organisera une conférence téléphonique et un webinaire audio en direct pour les analystes et les investisseurs à 8h00, heure de l'Est, le même jour.
Les participants souhaitant rejoindre par téléphone doivent s'inscrire à l'avance sur le site Internet des Relations Investisseurs de l'entreprise. Le communiqué de presse des résultats financiers sera disponible sur le site Internet de l'entreprise dans la section Relations Investisseurs. Un enregistrement du webinaire sera accessible pendant deux semaines après l'appel.
Twist Bioscience (NASDAQ: TWST) hat bekannt gegeben, dass die Finanzergebnisse des ersten Quartals des Geschäftsjahres 2025 für den Zeitraum bis zum 31. Dezember 2024 vor der Markteröffnung am 3. Februar 2025 veröffentlicht werden. Das Unternehmen wird am selben Tag um 8:00 Uhr Eastern Time eine Telefonkonferenz und eine Live-Audio-Webcast für Analysten und Investoren anbieten.
Teilnehmer, die telefonisch teilnehmen möchten, müssen sich im Voraus über die Investor-Relations-Website des Unternehmens registrieren. Die Pressemitteilung zu den Finanzergebnissen wird im Bereich Investor Relations auf der Website des Unternehmens verfügbar sein. Eine Wiederholung des Webcasts ist für zwei Wochen nach dem Anruf zugänglich.
- None.
- None.
Company to host conference call at 8:00 AM ET
SOUTH SAN FRANCISCO--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that it will issue its financial results for the fiscal 2025 first quarter ended December 31, 2024, before the opening of the market on February 3, 2025. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time to discuss its financial results and provide an update on the company’s business. The press release with the financial results will be accessible from the company’s website prior to the conference call through the Investor Relations section under the “Company” tab at www.twistbioscience.com.
The conference call will be webcast live through the Investor Relations section under the “Company” tab at www.twistbioscience.com. Those parties interested in participating via telephone must register on the Company’s Investor Relations website or by clicking here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the call. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast replay will be available for two weeks.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
Follow us on LinkedIn | X | YouTube | Instagram | Bluesky
View source version on businesswire.com: https://www.businesswire.com/news/home/20250122376470/en/
For Investors:
Angela Bitting
SVP, Corporate Affairs
925-202-6211
abitting@twistbioscience.com
For Media:
Amanda Houlihan
Communications Manager
774-265-5334
ahoulihan@twistbioscience.com
Source: Twist Bioscience Corporation
FAQ
When will Twist Bioscience (TWST) release its Q1 2025 earnings?
What time is Twist Bioscience's (TWST) Q1 2025 earnings call?
How can investors join Twist Bioscience's (TWST) Q1 2025 earnings call?
How long will Twist Bioscience's (TWST) Q1 2025 earnings call replay be available?
